| Biological Sciences | 2021-2025 | 413 | US 89 | 99.56 |
| Medical Physiology | Lifetime | 10 | US 8 | 99.98 |
| Neuroscience of Neurology | Lifetime | 109 | US 43 | 99.14 |
| Psychiatry and Mental health | Lifetime | 388 | US 201 | 98.75 |
| Cellular and Molecular Neuroscience | Lifetime | 930 | US 469 | 95.28 |
| Medical Physiology | 2021-2025 | 13 | US 8 | 99.79 |
| Neuroscience of Neurology | 2021-2025 | 9 | US 4 | 99.43 |
| Molecular Biology | 2021-2025 | 915 | US 258 | 94.85 |
| Psychiatry and Mental health | 2021-2025 | 319 | US 121 | 91.90 |
| Cognitive Neuroscience | 2021-2025 | 565 | US 236 | 88.99 |
| Alzheimer's disease research and treatments | Lifetime | 4 | US 3 | 99.99 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 6 | US 5 | 99.93 |
| S100 Proteins and Annexins | Lifetime | 6 | US 1 | 99.58 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 18 | US 10 | 99.76 |
| Dementia and Cognitive Impairment Research | Lifetime | 37 | US 20 | 99.86 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 16 | US 8 | 99.82 |
| Nuclear Receptors and Signaling | Lifetime | 13 | US 10 | 99.73 |
| Inflammation biomarkers and pathways | Lifetime | 6 | US 3 | 99.13 |
| Computational Drug Discovery Methods | Lifetime | 124 | US 59 | 99.10 |
| Neonatal and fetal brain pathology | Lifetime | 151 | US 73 | 98.81 |
| Tryptophan and brain disorders | Lifetime | 282 | US 128 | 98.46 |
| Prion Diseases and Protein Misfolding | Lifetime | 104 | US 46 | 98.05 |
| Sleep and Wakefulness Research | Lifetime | 290 | US 140 | 98.11 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 175 | US 86 | 97.68 |
| Sleep and related disorders | Lifetime | 420 | US 203 | 97.15 |
| Clusterin in disease pathology | Lifetime | 22 | US 8 | 96.21 |
| Nerve injury and regeneration | Lifetime | 589 | US 262 | 96.71 |
| Cholesterol and Lipid Metabolism | Lifetime | 435 | US 203 | 96.06 |
| Health, Environment, Cognitive Aging | Lifetime | 941 | US 462 | 90.09 |
| Down syndrome and intellectual disability research | Lifetime | 309 | US 125 | 89.90 |
| Cerebrovascular and genetic disorders | Lifetime | 504 | US 130 | 83.72 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 1 | US 1 | 99.96 |
| Alzheimer's disease research and treatments | 2021-2025 | 10 | US 6 | 99.92 |
| Tryptophan and brain disorders | 2021-2025 | 19 | US 3 | 99.20 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 83 | US 37 | 99.09 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 19 | US 4 | 97.84 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 97 | US 24 | 93.01 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 48 | US 11 | 90.40 |
| Sleep and Wakefulness Research | 2021-2025 | 492 | US 163 | 89.52 |
| Inflammation biomarkers and pathways | 2021-2025 | 69 | US 14 | 78.21 |
| S100 Proteins and Annexins | 2021-2025 | 496 | US 107 | 70.33 |
| Nuclear Receptors and Signaling | 2021-2025 | 294 | US 64 | 70.55 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 462 | US 137 | 66.16 |
